by David E. WilliamsHealth Business BlogTwo Congressional Reps have introduced a bill to create a pathway for generic biopharmaceuticals. It seems to me like a big waste of time.The bill has the following key provisions, according to Kaiser Daily Health Policy Report:12-14.5 years of market exclusivity for the original product before generics can appear Clinical trial requirements for follow-on products, which could be waived by FDA (I dont have more d[...]
Read More...
[Source: The Money Blogs]
No comments:
Post a Comment